• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Fat Tail Daily

Investment Ideas From the Edge of the Bell Curve

  • Menu
    • Commodities
      • Resources and Mining
      • Copper
      • Gold
      • Iron Ore
      • Lithium
      • Silver
      • Graphite
      • Rare Earths
    • Technology
      • AI
      • Bitcoin
      • Cryptocurrency
      • Energy
      • Financial Technology
      • Bio Technology
    • Market Analysis
      • Latest ASX News
      • Dividend Shares
      • ETFs
      • Stocks and Bonds
    • Macro
      • Australian Economy
      • Central Banks
      • World Markets
    • Small Caps
    • More
      • Investment Guides
      • Premium Research
      • Editors
      • About
      • Contact Us
  • Latest
  • Fat Tail Series
  • About Us
Market Analysis Latest ASX News

ALS [ASX:ALQ] Delivers 23.4% Underlying NPAT Increase for FY23

Like 0

By Mahlia Stewart, Monday, 29 May 2023

ALS has reported underlying NPAT of $321 million for FY2023 — an increase of 23.4% on last year thanks to high-performing divisions.

Testing, inspection, certification, and verification services group ALS [ASX:ALQ] has reported a strong year for fiscal 2023 — proving its performance with a 23.4% increase in underlying net profit after tax (NPAT).

By lunchtime on Monday, ALS shares had dropped by 4% when they were trading for around $11.77 each.

The industrial services stock has plummeted by 10% in the past month and nearly 8% in the last 12 months.

In its sector, the group is also down by more than 12% and more than 8% below the market average:

ASX:ALQ ALS Stock chart news 2023

Source: Market Index

 

ALS posts strong results for FY23

ALS has said that it has managed a 23.6% increase in underlying NPAT for FY2023.

Underlying continuing revenue of $2.4 billion increased 19.5% (18.3% in constant currency) which the group said was due to strong performance within the environmental, geochemistry and metallurgy businesses, and was further supported by acquisitions within the life sciences division.

Statutory NPAT had reached $291 million — which was again a significant jump of 52.9% — and which it said was supported by a reduction in one-off costs in the year.

The group maintained its operating margins, with underlying EBIT (earnings before interest and tax) from continuing operations of $491 million, an increase of 21.8%.

This was a reflection on the group’s margin of 20.3% — an expansion of 38 basis points — and followed a strategy of well-managed inflation across most of its businesses.

Overall, the group exceeded its guidance that was last provided in March by delivering an underlying continuing NPAT of $321 million. Furthermore, it executed 13 new acquisitions which contributed $115 million of revenue on a full-year run-rate basis.

ALS progressed with a solid cash conversion of 97% of underlying EBITDA, despite working capital increases in order to support its growth.

The group continues with underlying earnings per share (EPS) of 66.3 cents each — a rise of 23.3% — and statutory EPS of 60.2 cents per share — an increase of 52.7%.

Bruce Phillips, ALS Chairman commented:

‘This was another strong performance by our global business. Underlying continuing NPAT was up 23.4% YoY, exceeding the top end of our revised market guidance.

‘The company is continuing to demonstrate its resilience in operating through challenging periods of global instability, high inflation, and economic uncertainty.

‘Pleasingly, the company’s performance supports the declaration of a 21% increase YoY in dividends for our shareholders.’

By the end of the year, ALS’s board decided to declare a final dividend of 19.4 cents a share, which was partially franked by 10%.

This has taken the total fiscal year’s dividend to 39.7 cents a share — up 21% in comparison with the end of the 2022 financial year — and represents a payout ratio of 60% of FY23 underlying NPAT.

ALS believes the medium to long-term outlook across both life sciences and commodities remains supportive, particularly with life sciences. Additionally, the environmental business looks to continue performing well across all geographies, managing inflationary headwinds with success.

There may yet be some challenging market conditions ahead for geochemistry, however. Careful management of capacity, cost and pricing may mitigate impacts, and metallurgy is also expected to benefit from a strong pipeline of opportunities.

 

Sold Out — Jim Rickards’ book offer

Why are bank branches closing, prices still skyrocketing, and packaging shrinking?

Is it all just inflation, COVID ramifications and market volatility, or is there more to the story?

Jim Rickards, the man who forecast Trump, Brexit, Ukraine, and COVID, now says these signs are pointing to something bigger.

He says these mere ‘inconveniences’ are just the start.

He explains it all in his book, SOLD OUT: How Broken Supply Chains, Surging Inflation, and Political Instability Will Sink the Global Economy.

You can grab a free copy when you sign up for The Daily Reckoning Australia — also free — right here.

 

Regards,

Mahlia Stewart

For The Daily Reckoning Australia

All advice is general advice and has not taken into account your personal circumstances.

Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

Mahlia Stewart

Mahlia’s Premium Subscriptions

Publication logo
Fat Tail Investment Research

Latest Articles

  • Google Search Isn’t Dead, It Just Smells Funny
    By Charlie Ormond

    The question isn't whether this disruption will happen, but whether you're positioned to profit from it.

  • Trump sparks uranium rally
    By Callum Newman

    Tune in today to watch the latest Closing Bell podcast with Murray Dawes. We discuss the outlook for US stocks, uranium, RBA “bulltish”…plus discuss a few stocks. Tune in now!

  • Markets on Edge? Who cares, this Explorer just delivered a 1,600m Hit
    By James Cooper

    James Cooper outlines the potential opportunities among explorers making major drill hits, but aren’t capturing attention from investors, yet.

Primary Sidebar

Latest Articles

  • Google Search Isn’t Dead, It Just Smells Funny
  • Trump sparks uranium rally
  • Markets on Edge? Who cares, this Explorer just delivered a 1,600m Hit
  • Just “ChatGPT It”, Stupid
  • The blunder that cost Australia $28 billion

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2025 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988